{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T17:25:37Z","timestamp":1769621137228,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,27]]},"DOI":"10.7759\/cureus.102443","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:25:00Z","timestamp":1769574300000},"source":"Crossref","is-referenced-by-count":0,"title":["Impact of Symptomatic Versus Asymptomatic Breast Cancer Recurrence on Survival: A Retrospective Study of 238 Patients"],"prefix":"10.7759","author":[{"given":"Jun","family":"Yamamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shione","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maika","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Kamigaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"National Cancer Institute. Female breast cancer. (2025). Accessed: December 5, 2025: http:\/\/seer.cancer.gov\/statfacts\/html\/breast.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-076962","article-title":"25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis","volume":"384","author":"Shelton J","year":"2024","unstructured":"Shelton J, Zotow E, Smith L, et al.. 25 year trends in cancer incidence and mortality among adults aged 35-69 years in the UK, 1993-2018: retrospective secondary analysis. BMJ. 2024, 384:e076962. 10.1136\/bmj-2023-076962","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.5301\/tj.5000301","article-title":"Trends in survival for patients with metastatic breast cancer: is survival improving?","volume":"101","author":"Giuliani J","year":"2015","unstructured":"Giuliani J, Bonetti A. Trends in survival for patients with metastatic breast cancer: is survival improving?. Tumori. 2015, 101:347-52. 10.5301\/tj.5000301","journal-title":"Tumori"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.8-6-514","article-title":"Goals and objectives in the management of metastatic breast cancer","volume":"8","author":"Chung CT","year":"2003","unstructured":"Chung CT, Carlson RW. Goals and objectives in the management of metastatic breast cancer. Oncologist. 2003, 8:514-20. 10.1634\/theoncologist.8-6-514","journal-title":"Oncologist"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S72592","article-title":"Management of patients with hormone receptor-positive breast cancer with visceral disease: challenges and treatment options","volume":"7","author":"Harb WA","year":"2015","unstructured":"Harb WA. Management of patients with hormone receptor-positive breast cancer with visceral disease: challenges and treatment options. Cancer Manag Res. 2015, 7:37-46. 10.2147\/CMAR.S72592","journal-title":"Cancer Manag Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001768.pub2","article-title":"Follow-up strategies for women treated for early breast cancer","author":"Rojas MP","year":"2005","unstructured":"Rojas MP, Telaro E, Russo A, et al.. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev. 2005, CD001768. 10.1002\/14651858.CD001768.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001768.pub3","article-title":"Follow-up strategies for women treated for early breast cancer","volume":"2016","author":"Moschetti I","year":"2016","unstructured":"Moschetti I, Cinquini M, Lambertini M, et al.. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev. 2016, 2016:CD001768. 10.1002\/14651858.CD001768.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.amsu.2021.102272","article-title":"The effectiveness of mammography surveillance after treatment of primary breast cancer: A single centre retrospective cohort study","volume":"65","author":"Taher W","year":"2021","unstructured":"Taher W, Benson J, Leinster S. The effectiveness of mammography surveillance after treatment of primary breast cancer: A single centre retrospective cohort study. Ann Med Surg (Lond). 2021, 65:102272. 10.1016\/j.amsu.2021.102272","journal-title":"Ann Med Surg (Lond)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.10070","article-title":"St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up","volume":"103","author":"Falck AK","year":"2016","unstructured":"Falck AK, R\u00f6me A, Fern\u00f6 M, et al.. St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up. Br J Surg. 2016, 103:513-23. 10.1002\/bjs.10070","journal-title":"Br J Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djac131","article-title":"Surveillance imaging vs symptomatic recurrence detection and survival in stage II-III breast cancer (AFT-01)","volume":"114","author":"Schumacher JR","year":"2022","unstructured":"Schumacher JR, Neuman HB, Yu M, et al.. Surveillance imaging vs symptomatic recurrence detection and survival in stage II-III breast cancer (AFT-01). J Natl Cancer Inst. 2022, 114:1371-9. 10.1093\/jnci\/djac131","journal-title":"J Natl Cancer Inst"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.9859","article-title":"Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Khatcheressian JL","year":"2013","unstructured":"Khatcheressian JL, Hurley P, Bantug E, et al.. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013, 31:961-5. 10.1200\/JCO.2012.45.9859","journal-title":"J Clin Oncol"},{"key":"ref12","unstructured":"National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology. (2025). Accessed: December 5, 2025: https:\/\/www.nccn.org\/EvidenceBlocks\/."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen J","year":"2022","unstructured":"Haanen J, Obeid M, Spain L, et al.. Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2022, 33:1217-38. 10.1016\/j.annonc.2022.10.001","journal-title":"Ann Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2017.04.001","article-title":"Interval breast cancer versus screen-detected cancer: comparison of clinicopathologic characteristics in a single-center analysis","volume":"17","author":"Bellio G","year":"2017","unstructured":"Bellio G, Marion R, Giudici F, et al.. Interval breast cancer versus screen-detected cancer: comparison of clinicopathologic characteristics in a single-center analysis. Clin Breast Cancer. 2017, 17:564-71. 10.1016\/j.clbc.2017.04.001","journal-title":"Clin Breast Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2015.02.032","article-title":"A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer","volume":"24","author":"Meshkat B","year":"2015","unstructured":"Meshkat B, Prichard RS, Al-Hilli Z, et al.. A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer. Breast. 2015, 24:278-82. 10.1016\/j.breast.2015.02.032","journal-title":"Breast"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1748-z","article-title":"Impact of mammographic screening on the detection of good and poor prognosis breast cancers","volume":"130","author":"Esserman LJ","year":"2011","unstructured":"Esserman LJ, Shieh Y, Rutgers EJ, et al.. Impact of mammographic screening on the detection of good and poor prognosis breast cancers. Breast Cancer Res Treat. 2011, 130:725-34. 10.1007\/s10549-011-1748-z","journal-title":"Breast Cancer Res Treat"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-017-4340-3","article-title":"Patterns and predictors of first and subsequent recurrence in women with early breast cancer","volume":"165","author":"Geurts YM","year":"2017","unstructured":"Geurts YM, Witteveen A, Bretveld R, et al.. Patterns and predictors of first and subsequent recurrence in women with early breast cancer. Breast Cancer Res Treat. 2017, 165:709-20. 10.1007\/s10549-017-4340-3","journal-title":"Breast Cancer Res Treat"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-021-06233-4","article-title":"Factors associated with late risks of breast cancer-specific mortality in the SEER registry","volume":"189","author":"Leone JP","year":"2021","unstructured":"Leone JP, Vallejo CT, Hassett MJ, et al.. Factors associated with late risks of breast cancer-specific mortality in the SEER registry. Breast Cancer Res Treat. 2021, 189:203-12. 10.1007\/s10549-021-06233-4","journal-title":"Breast Cancer Res Treat"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1760","article-title":"Risk-based breast cancer follow-up stratified by age","volume":"7","author":"Witteveen A","year":"2018","unstructured":"Witteveen A, Otten JW, Vliegen IM, et al.. Risk-based breast cancer follow-up stratified by age. Cancer Med. 2018, 7:5291-8. 10.1002\/cam4.1760","journal-title":"Cancer Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2023.2150","article-title":"Locoregional recurrence patterns in patients with different molecular subtypes of breast cancer","volume":"158","author":"Cheun JH","year":"2023","unstructured":"Cheun JH, Kim HK, Moon HG, et al.. Locoregional recurrence patterns in patients with different molecular subtypes of breast cancer. JAMA Surg. 2023, 158:841-52. 10.1001\/jamasurg.2023.2150","journal-title":"JAMA Surg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.4048\/jbc.2023.26.e17","article-title":"Prognostic impact of elevation of cancer antigen 15-3 (CA15-3) in patients with early breast cancer with normal serum CA15-3 level","volume":"26","author":"Ryu JM","year":"2023","unstructured":"Ryu JM, Kang D, Cho J, et al.. Prognostic impact of elevation of cancer antigen 15-3 (CA15-3) in patients with early breast cancer with normal serum CA15-3 level. J Breast Cancer. 2023, 26:126-35. 10.4048\/jbc.2023.26.e17","journal-title":"J Breast Cancer"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-019-05357-y","article-title":"The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry","volume":"177","author":"Nam SE","year":"2019","unstructured":"Nam SE, Lim W, Jeong J, et al.. The prognostic significance of preoperative tumor marker (CEA, CA15-3) elevation in breast cancer patients: data from the Korean Breast Cancer Society Registry. Breast Cancer Res Treat. 2019, 177:669-78. 10.1007\/s10549-019-05357-y","journal-title":"Breast Cancer Res Treat"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1200\/JOP.2015.008953","article-title":"Curing metastatic breast cancer","volume":"12","author":"Sledge GW Jr","year":"2016","unstructured":"Sledge GW Jr. Curing metastatic breast cancer. J Oncol Pract. 2016, 12:6-10. 10.1200\/JOP.2015.008953","journal-title":"J Oncol Pract"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.20.3.620","article-title":"Can we cure limited metastatic breast cancer?","volume":"20","author":"Hortobagyi GN","year":"2002","unstructured":"Hortobagyi GN. Can we cure limited metastatic breast cancer?. J Clin Oncol. 2002, 20:620-3. 10.1200\/JCO.2002.20.3.620","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102434","article-title":"Rethinking breast cancer follow-up based on individual risk and recurrence management","volume":"109","author":"De Rose F","year":"2022","unstructured":"De Rose F, Meduri B, De Santis MC, et al.. Rethinking breast cancer follow-up based on individual risk and recurrence management. Cancer Treat Rev. 2022, 109:102434. 10.1016\/j.ctrv.2022.102434","journal-title":"Cancer Treat Rev"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6496-4","article-title":"A national study of the use of asymptomatic systemic imaging for surveillance following breast cancer treatment (AFT-01)","volume":"25","author":"Schumacher JR","year":"2018","unstructured":"Schumacher JR, Neuman HB, Chang GJ, et al.. A national study of the use of asymptomatic systemic imaging for surveillance following breast cancer treatment (AFT-01). Ann Surg Oncol. 2018, 25:2587-95. 10.1245\/s10434-018-6496-4","journal-title":"Ann Surg Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2014.03.001","article-title":"Follow-up of patients with early breast cancer: is it time to rewrite the story?","volume":"91","author":"Puglisi F","year":"2014","unstructured":"Puglisi F, Fontanella C, Numico G, et al.. Follow-up of patients with early breast cancer: is it time to rewrite the story?. Crit Rev Oncol Hematol. 2014, 91:130-41. 10.1016\/j.critrevonc.2014.03.001","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp037","article-title":"Early detection of second breast cancers improves prognosis in breast cancer survivors","volume":"20","author":"Houssami N","year":"2009","unstructured":"Houssami N, Ciatto S, Martinelli F, et al.. Early detection of second breast cancers improves prognosis in breast cancer survivors. Ann Oncol. 2009, 20:1505-10. 10.1093\/annonc\/mdp037","journal-title":"Ann Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/448912-impact-of-symptomatic-versus-asymptomatic-breast-cancer-recurrence-on-survival-a-retrospective-study-of-238-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:25:02Z","timestamp":1769574302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/448912-impact-of-symptomatic-versus-asymptomatic-breast-cancer-recurrence-on-survival-a-retrospective-study-of-238-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,27]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.102443","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,27]]}}}